Join us at upcoming conferences

Delft, April 2024 - DAB.bio is excited to announce our participation in several upcoming conferences over the next few months, which include SynBioBeta, Himmelfahrtstagung, and World Bio Markets.

The Global Synthetic Biology Conference – Speaking position

Date: 6-9 May 2024

Location: San Jose, California, USA

Attendees: Eric van der Meer - CEO & Willem-Jan Meijer - CCO

About the conference: It stands as one of the largest synthetic biology conferences globally, uniting various industries to shape the future of sustainable biomanufacturing. More information can be found on their website.

Himmelfahrtstagung on Bioprocess Engineering 2024 – Speaking

Date: 6-8 May 2024

Location: Regensburg, Germany

Attendees: Arjan Oudshoorn – Principal Engineer & Prof. Michael Kopf - Scientific Advisor

About the conference: An esteemed annual gathering where experts convene to both listen and engage in discussions surrounding the latest developments and innovations in the field of bioprocess engineering. More information can be found on their website.

World Bio Markets - Attending

Date: 26-27 June 2024

Location: The Hague, the Netherlands

Attendees: Eric van der Meer – CEO, Willem-Jan Meijer – CCO, Kirsten Steinbusch – Co-founder

About the conference: World Bio Markets serves as a pivotal event for leaders within the global bioeconomy community to foster connections and collaborations. More information can be found on their website.

If you're attending any of these conferences, we invite you to listen in to our sessions or schedule a meeting with us to learn how DAB offers continuous, extractive bioprocess solutions, facilitating sustainable and cost-effective biomanufacturing.

If you would like to receive the presentation beforehand and for other inquiries, please reach out to us at commerce@dab.bio or our LinkedIn.

About DAB.bio

DAB.bio is revolutionizing industrial biomanufacturing with its FAST™ platform technology. FAST™ combines fermentation with continuous product recovery to deliver the most efficient and cost-effective biomanufacturing platform available today. A spin out from Delft University of Technology, DAB.bio offers patented technology licensing and fermentation/process development services. Following nearly 10 years of R&D on its core technology, DAB.bio’s scalable solutions significantly lower biomanufacturing costs, enabling the cost-effective production of biorenewables. DAB.bio aims to accelerate the bioeconomy towards a net-zero future.